From a report
by Stephen D. Silberstein, MD
Neurologists and
other physicians who care for patients with migraine must be prepared to offer
appropriate preventive treatments… clinicians should be ready to offer
therapies with the greatest potential to reduce the frequency, severity, or
duration of migraines for that particular patient. The focus on
non-prescription and non-traditional interventions for migraine is especially
important. Although some clinicians are dismissive of complementary therapies,
the comprehensive literature review undertaken for the guideline development
shows that controlled trials have been conducted for some therapies.
Furthermore, some of these trials show that these non-prescription agents may
offer promise in the management of migraine. Those individuals interested in
treatment alternatives can be directed to agents with evidence.
Full report at http://bmctoday.net/practicalneurology/2012/06/article.asp?f=new-guidelines-update-approach-to-episodic-migraine-prevention
Stephen D.
Silberstein, MD is Professor of Neurology and Director of the Jefferson
Headache Center at Thomas Jefferson University. He is a Fellow of the American
College of Physicians (ACP) and the American Headache Society (AHS), and the
American Academy of Neurology (AAN).
